145 related articles for article (PubMed ID: 11868058)
1. The impact of tranilast on restenosis after coronary angioplasty: the Second Tranilast Restenosis Following Angioplasty Trial (TREAT-2).
Tamai H; Katoh K; Yamaguchi T; Hayakawa H; Kanmatsuse K; Haze K; Aizawa T; Nakanishi S; Suzuki S; Suzuki T; Takase S; Nishikawa H; Katoh O
Am Heart J; 2002 Mar; 143(3):506-13. PubMed ID: 11868058
[TBL] [Abstract][Full Text] [Related]
2. Impact of tranilast on restenosis after coronary angioplasty: tranilast restenosis following angioplasty trial (TREAT).
Tamai H; Katoh O; Suzuki S; Fujii K; Aizawa T; Takase Si; Kurogane H; Nishikawa H; Sone T; Sakai K; Suzuki T
Am Heart J; 1999 Nov; 138(5 Pt 1):968-75. PubMed ID: 10539831
[TBL] [Abstract][Full Text] [Related]
3. Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial.
Holmes DR; Savage M; LaBlanche JM; Grip L; Serruys PW; Fitzgerald P; Fischman D; Goldberg S; Brinker JA; Zeiher AM; Shapiro LM; Willerson J; Davis BR; Ferguson JJ; Popma J; King SB; Lincoff AM; Tcheng JE; Chan R; Granett JR; Poland M
Circulation; 2002 Sep; 106(10):1243-50. PubMed ID: 12208800
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of neointima formation by tranilast in pig coronary arteries after balloon angioplasty and stent implantation.
Ishiwata S; Verheye S; Robinson KA; Salame MY; de Leon H; King SB; Chronos NA
J Am Coll Cardiol; 2000 Apr; 35(5):1331-7. PubMed ID: 10758977
[TBL] [Abstract][Full Text] [Related]
5. Geographical differences in the rates of angiographic restenosis and ischemia-driven target vessel revascularization after percutaneous coronary interventions: results from the Prevention of Restenosis With Tranilast and its Outcomes (PRESTO) Trial.
Singh M; Williams BA; Gersh BJ; McClelland RL; Ho KK; Willerson JT; Penny WF; Cutlip DE; Holmes DR
J Am Coll Cardiol; 2006 Jan; 47(1):34-9. PubMed ID: 16386661
[TBL] [Abstract][Full Text] [Related]
6. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
Hermans WR; Foley DP; Rensing BJ; Serruys PW
Am Heart J; 1994 Mar; 127(3):483-94. PubMed ID: 8122593
[TBL] [Abstract][Full Text] [Related]
7. The PRESTO (Prevention of restenosis with tranilast and its outcomes) protocol: a double-blind, placebo-controlled trial.
Holmes D; Fitzgerald P; Goldberg S; LaBlanche Jm; Lincoff AM; Savage M; Serruys PW; Willerson J; Granett JR; Chan R; Shusterman NH; Poland M
Am Heart J; 2000 Jan; 139(1 Pt 1):23-31. PubMed ID: 10618558
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of tranilast on restenosis after directional coronary atherectomy.
Kosuga K; Tamai H; Ueda K; Hsu YS; Ono S; Tanaka S; Doi T; Myou-U W; Motohara S; Uehata H
Am Heart J; 1997 Oct; 134(4):712-8. PubMed ID: 9351739
[TBL] [Abstract][Full Text] [Related]
9. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
[TBL] [Abstract][Full Text] [Related]
10. Application of in vivo and ex vivo magnetic resonance imaging for evaluation of tranilast on neointima formation following balloon angioplasty of the rat carotid artery.
Ohlstein EH; Romanic AM; Clark LV; Kapadia RD; Sarkar SK; Gagnon R; Chandra S
Cardiovasc Res; 2000 Sep; 47(4):759-68. PubMed ID: 10974224
[TBL] [Abstract][Full Text] [Related]
11. No effect of highly dosed nitric oxide donor molsidomine on the angiographic restenosis rate after percutaneous coronary angioplasty: a randomized, placebo controlled, double-blind trial.
Wöhrle J; Höher M; Nusser T; Hombach V; Kochs M
Can J Cardiol; 2003 Apr; 19(5):495-500. PubMed ID: 12717484
[TBL] [Abstract][Full Text] [Related]
12. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
Circulation; 1992 Jul; 86(1):100-10. PubMed ID: 1535568
[TBL] [Abstract][Full Text] [Related]
13. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.
Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N
Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676
[TBL] [Abstract][Full Text] [Related]
14. Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
Maresta A; Balducelli M; Latini R; Bernardi G; Moccetti T; Sosa C; Barlera S; Varani E; Ribeiro da Silva EE; Monici Preti A; Maggioni AP;
Catheter Cardiovasc Interv; 2005 Mar; 64(3):375-82. PubMed ID: 15736248
[TBL] [Abstract][Full Text] [Related]
15. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.
Serruys PW; Foley DP; Jackson G; Bonnier H; Macaya C; Vrolix M; Branzi A; Shepherd J; Suryapranata H; de Feyter PJ; Melkert R; van Es GA; Pfister PJ
Eur Heart J; 1999 Jan; 20(1):58-69. PubMed ID: 10075142
[TBL] [Abstract][Full Text] [Related]
16. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
[TBL] [Abstract][Full Text] [Related]
17. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
[TBL] [Abstract][Full Text] [Related]
18. Pravastatin reduces restenosis after coronary angioplasty of high grade stenotic lesions: results of SHIPS (SHIga Pravastatin Study).
Nakamura Y; Yamaoka O; Uchida K; Morigami N; Sugimoto Y; Fujita T; Inoue T; Fuchi T; Hachisuka M; Ueshima H; Shimakawa H; Kinoshita M
Cardiovasc Drugs Ther; 1996 Sep; 10(4):475-83. PubMed ID: 8924063
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty. A multicenter randomized double-blind placebo-controlled trial.
Serruys PW; Klein W; Tijssen JP; Rutsch W; Heyndrickx GR; Emanuelsson H; Ball SG; Decoster O; Schroeder E; Liberman H
Circulation; 1993 Oct; 88(4 Pt 1):1588-601. PubMed ID: 8403306
[TBL] [Abstract][Full Text] [Related]
20. Metoprolol treatment to prevent restenosis following percutaneous transluminal coronary angioplasty.
Franzen D; Seifert N; Metha A; Höpp HW
Cardiology; 2002; 97(2):94-8. PubMed ID: 11978956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
